Deeper dissecting the regulation of the PRL-3-integrin β1-ERK1/2-MMP2 pathway may have a therapeutic implication for prognosis and treatment for colon cancer metastasis. This evidence concerns the gene MAPK3 and malignant colon neoplasm.